News|Articles|November 14, 2023
Infection Intel: AstraZeneca, DayZero and Oxford Nanopore, and More
Staying Ahead with Company Updates and Product Innovations. This week's news is from AstraZeneca, DayZero and Oxford Nanopore, Ohmnilab, and NIH.
Advertisement
Infection Intel is the column for Infection Control Today® (ICT®) that covers the latest news, including updates on product developments, mergers, and more from companies in the infection control and prevention field.
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Infection Control Today
1
AORN26: Teach-Back Method in PACU Discharge Education Reduces Surgical Site Infections
2
AORN26: Evidence-Based Colorectal SSI Bundle Translates Research Into Practice at VA Medical Center
3
AORN26: Multidisciplinary Culture Change Cuts Colon SSI Rates by Over 27%
4
AORN26: OR–SPD Collaboration Reduces Instrument Contamination and Improves Surgical Efficiency
5